In another step towards personalized medical treatment for dementia patients, Canadian researchers have used artificial intelligence to predict the progression of neurodegenerative diseases such…
Whether it’s diet, exercise or air pollution, researchers are constantly investigating lifestyle and environmental factors that may play a role in the progression or…
The U.S. Food and Drug Administration (FDA) has approved a re-dosing study for patients formerly enrolled in Biogen’s phase three clinical trials of its…
The study was in mice and the findings are still very preliminary, but researchers at Case Western University School of Medicine have identified a…
Being Patient spoke with Dr. Peter Snyder about his research into retinal scanning technology that may be able to identify markers of Alzheimer’s disease,…
Decades ago, a chaperone was a person who accompanied an unmarried girl in public. Now, however, we’re learning that a chaperone — in this…
A new study by Houston Methodist scientists finds that a protein linked to ovarian cancer may contribute to the development of Alzheimer’s disease. The…
Biogen has agreed to buy an experimental Alzheimer’s and Parkinson’s treatment from Pfizer, the company announced Monday. In the agreed deal, Biogen will pay…
Can a simple eye exam detect Alzheimer’s disease? Researchers in Rhode Island and Florida have launched a $5 million study that could allow doctors…
Scientists are continuing to search for answers to Alzheimer’s disease and other dementias, targeting beta-amyloid and tau protein, inflammation, and genetic factors in research…
Scientists are increasingly certain that Alzheimer’s and other dementias are caused by many factors. Genetics certainly play a major role, but researchers are increasingly…
When it comes to Alzheimer’s, what happens first: beta amyloid plaques, or the visible personality and cognitive changes common with the disease? Researchers have…
With repeated drug failures to treat Alzheimer’s disease in recent years, scientists are racing to find a vaccine to prevent the disease from evolving….
Chinese officials announced conditional approval to a seaweed-based drug in November. Now, it’s available on the Chinese market. Oligomannate is the first drug to…
The exact causes behind dementia are varied and at times unclear. We know that genetic factors — like carrying the APOE4 gene — can…